Tag Archives: Sanofi

U.S. FDA’s Nonprescription Drugs Advisory Committee recommends approval of Sanofi’s Nasacort AQ Nasal Spray for over-the-counter use in the U.S.

Posted on 6, August 2013 by

Treats Seasonal and Year-round Nasal Allergy Symptoms in Adults and Children  Paris, France, 06-8-2013 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that the U.S. Food and Drug Administration’s (FDA) Nonprescription Drugs Advisory Committee (NDAC) voted 10 to … Read the full press release →

Posted in Business, France, Government, Healthcare, Pharma & Biotech, Science

Tagged , , , , , , , , , , , , , , , , , , , , , , , ,

Sanofi vaccines division Sanofi Pasteur initiated Cdiffense Phase III Study of investigational vaccine for prevention of primary symptomatic Clostridium difficile infection (CDI)

Posted on 6, August 2013 by

Cdiffense trial to evaluate vaccine against a leading cause of life-threatening, healthcare-associated infections worldwide Lyon, France, 06-8-2013 — /EuropaWire/ — Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program … Read the full press release →

Posted in Business, France, Healthcare, Pharma & Biotech, Science

Tagged , , , , , , , , , , , , , ,